Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Long-Term Debt Issuances (2009 - 2025)

Updated

Analysis

Elite Pharmaceuticals (ELTP) Long-Term Debt Issuances (2009 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 9.98 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -4.00 Mn
Jun 30, 2023 4.00 Mn
Mar 31, 2023 -111,016.00
Dec 31, 2022 1.00
Sep 30, 2022 2.55 Mn
Jun 30, 2022 12.00 Mn
Mar 31, 2021 -1.20 Mn
Jun 30, 2020 1.01 Mn
Mar 31, 2018 -1.00
Dec 31, 2016 10,634.00
Mar 31, 2011 253,081.00
Sep 30, 2010 62,500.00
Jun 30, 2009 258,700.00
API Access

Elite Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ELTP&period=max&api_key=YOUR_API_KEY